Tocols induce G-CSF and mobilise progenitors that mitigate radiation injury

Radiation Protection Dosimetry

Volumn 162, Issue 1-2, 2014, Pages 83-87

  Singh, Vijay K ^a   Romaine, P L P ^a   Newman, P L ^a   Seed, T M ^b  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^b Tech Micro Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; HETEROCYCLIC COMPOUND; PLERIXAFOR; RADIOPROTECTIVE AGENT; TOCOL; TOCOPHEROL;

ADVERSE EFFECTS; ANIMAL; GAMMA RADIATION; MALE; METABOLISM; MONONUCLEAR CELL; MOUSE; RADIATION INJURIES; STEM CELL MOBILIZATION; TRANSPLANTATION;

ANIMALS; ANTI-HIV AGENTS; GAMMA RAYS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HETEROCYCLIC COMPOUNDS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; TOCOPHEROLS;

EID: 84912558967     PISSN: 01448420     EISSN: 17423406     Source Type: Journal    
DOI: 10.1093/rpd/ncu223     Document Type: Article

References (25)

1. DiCarlo, A. L., Maher, C., Hick, J. L., Hanfling, D., Dainiak, N., Chao, N., Bader, J. L., Coleman, C. N. and Weinstock, D. M. Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation. Disaster Med. Public Health Prep. 5 Suppl 1, S32-S44 (2011).
2. Singh, V. K., Beattie, L. A. and Seed, T. M. Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures. J. Radiat. Res. 54, 973-988 (2013).
3. Nesaretnam, K. Multitargeted therapy of cancer by tocotrienols. Cancer Lett. 269, 388-395 (2008).
4. Sen, C. K., Khanna, S., Roy, S. and Packer, L. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J. Biol. Chem. 275, 13049-13055 (2000).
5. Luk, S. U. et al. Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int. J. Cancer 128, 2182-2191 (2011).
6. Hussein, D. and Mo, H. d-delta-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas 38, e124-e136 (2009).
7. Pearce, B. C., Parker, R. A.,Deason,M. E., Qureshi, A. A. andWright, J. J. Hypocholesterolemic activity of synthetic and natural tocotrienols. J.Med. Chem. 35, 3595-3606 (1992).
8. Singh, V. K., Ducey, E. J., Brown, D. S. and Whitnall, M. H. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int. J. Radiat. Biol. 88, 296-310 (2012).
9. Singh, V. K., Christensen, J., Fatanmi, O. O., Gille, D., Ducey, E. J., Wise, S. Y., Karsunky, H. and Sedello, A. K. Myeloid progenitors: a radiation countermeasure that is effective when initiated days after irradiation. Radiat. Res. 177, 781-791 (2012).
10. Nagy, V. V. Accuracy considerations in EPR dosimetry. Appl. Radiat. Isot. 52, 1039-1050 (2000).
11. ISO-ASTM Standard practice for use of an alanine dosimetry. ISO/ASTM International Standard 5167 (Geneva, Switzerland: ASTM International) (2004).
12. Singh, V. K., Wise, S. Y., Scott, J. R., Romaine, L. P., Newman, V. L. and Fatanmi, O. O. Radioprotective efficacy of delta-tocotrienol, a vitamin E isoform, is mediated through granulocyte colony-stimulating factor. Life Sci. 98, 113-122 (2014).
13. Singh, V. K., Brown, D. S. and Kao, T. C. Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor. Int. J. Radiat. Biol. 86, 12-21 (2010).
14. Kulkarni, S., Singh, P. K., Ghosh, S. P., Posarac, A. and Singh, V. K. Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gammatocotrienol, a promising radiation countermeasure. Cytokine 62, 278-285 (2013).
15. Broxmeyer, H. E. et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 201, 1307-1318 (2005).
16. Singh, V. K., Singh, P. K., Wise, S. Y. and Seed, T. M. Mobilized progenitor cells as a bridging therapy for radiation casualties: a brief review of tocopherol succinatebased approaches. Int. Immunopharmacol. 11, 842-847 (2011).
17. Schaue, D., Kachikwu, E. L. and McBride, W. H. Cytokines in radiobiological responses: a review. Radiat. Res. 178, 505-523 (2012).
18. Krivokrysenko, V. I. et al. Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure. J. Pharmacol. Exp. Ther. 343, 497-508 (2012).
19. Shakhov, A. N. et al. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2). PLoS one 7, e33044 (2012).
20. Singh, V. K., Ducey, E. J., Fatanmi, O. O., Singh, P. K., Brown, D. S., Purmal, A., Shakhova, V. V., Gudkov, A. V., Feinstein, E. and Shakhov, A. CBLB613: A TLR 2/6 agonist, natural lipopeptide of Mycoplasma arginini, as a novel radiation countermeasure. Radiat. Res. 177, 628-642 (2012).
21. Singh, V. K., Fatanmi, O. O., Singh, P. K. and Whitnall, M. H. Role of radiation-induced granulocyte colonystimulating factor in recovery from whole body gamma-irradiation. Cytokine 58, 406-414 (2012).
22. Farese, A. M., Cohen, M. V., Katz, B. P., Smith, C. P., Gibbs, A., Cohen, D. M. and MacVittie, T. J. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat. Res. 179, 89-100 (2013).
23. Farese, A. M., Cohen, M. V., Stead, R. B., Jackson, W. III and Macvittie, T. J. Pegfilgrastim administered in an abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced myelosuppression in rhesus macaques. Radiat.Res. 178, 403-413 (2012).
24. Kim, J. S., Ryoo, S. B., Heo, K., Kim, J. G., Son, T. G., Moon, C. and Yang, K. Attenuating effects of Granulocyte-colony stimulating factor (G-CSF) in radiation induced intestinal injury in mice. Food Chem. Toxicol. 50, 3174-3180 (2012).
25. Moroni, M., Ngudiankama, B. F., Christensen, C., Olsen, C. H., Owens, R., Lombardini, E. D., Holt, R. K. andWhitnall, M. H. The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body gamma-irradiation. Int. J. Radiat. Oncol. Biol. Phys. 86, 986-992 (2013).